Form 4: LeMaitre Vascular CEO Exercises Stock Options, Increases Holdings

LeMaitre Vascular's CEO, George W. LeMaitre, exercised stock options, acquiring 2,818 shares of common stock.

Summary

• George W. LeMaitre, the Chairman and CEO of LeMaitre Vascular, Inc., exercised stock options on November 22, 2024.
• This transaction resulted in the acquisition of 2,818 shares of common stock at a price of $39.03 per share.
• Following the transaction, Mr. LeMaitre directly owns 1,889,454 shares of LeMaitre Vascular common stock.
• The exercised options were part of a grant that vests over a five-year period, with the initial 20% vesting on December 20, 2019, and the remainder vesting in equal annual installments.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed positively as it aligns management's interests with shareholders. There is no indication of any negative sentiment.

Positives

• The CEO's exercise of stock options demonstrates confidence in the company's future performance.
• The increase in the CEO's direct share ownership aligns his interests with those of other shareholders.

Industry Context

This is a routine filing related to executive compensation and is common in publicly traded companies. It reflects the CEO's participation in the company's equity incentive plans.

Comparison to Industry Standards

• Stock option exercises are a standard form of executive compensation in the medical device industry, similar to practices at companies like Medtronic and Boston Scientific.
• The vesting schedule of the options, with a five-year vesting period, is also typical for executive stock option grants.

Stakeholder Impact

• The increase in the CEO's share ownership may be viewed positively by shareholders, as it aligns his interests with theirs.

Key Dates

Keywords

stock options, insider trading, share acquisition, executive compensation, beneficial ownership, LMAT, LeMaitre Vascular